Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington’s disease

Huntington’s disease is a progressive neurodegenerative disorder characterized by motor, cognitive and psychiatric symptoms. Currently, no disease-modifying therapies are available to slow or halt disease progression. Huntington’s disease is characterized by relatively focal and specific loss of str...

Descripción completa

Detalles Bibliográficos
Autores principales: Drew, Cheney J G, Sharouf, Feras, Randell, Elizabeth, Brookes-Howell, Lucy, Smallman, Kim, Sewell, Bernadette, Burrell, Astrid, Kirby, Nigel, Mills, Laura, Precious, Sophie, Pallmann, Philip, Gillespie, David, Hood, Kerry, Busse, Monica, Gray, William P, Rosser, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850012/
https://www.ncbi.nlm.nih.gov/pubmed/33543141
http://dx.doi.org/10.1093/braincomms/fcaa230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850012/
https://www.ncbi.nlm.nih.gov/pubmed/33543141
http://dx.doi.org/10.1093/braincomms/fcaa230

Ejemplares similares